We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Ribonucleotide Reductase
From Proteopedia
(Difference between revisions)
| Line 14: | Line 14: | ||
== Disease == | == Disease == | ||
| - | Activity of RNR is controlled by substrate specificity and enzymatic activity. Substrate activity functions by allowing the binding of different nucleotides which results in the reduction of a specific NTP. This regulation occurs at the active site. ATP or dATP can bind to activate or inhibit activity which allows for enzymatic activity to be controlled. Mutations can occur within the genome if there is an imbalance in the pools of dNTPs. These are the building blocks for DNA, and if the pool is altered, then it can lead to genomic instability. <ref name="disease"> | + | Activity of RNR is controlled by substrate specificity and enzymatic activity. Substrate activity functions by allowing the binding of different nucleotides which results in the reduction of a specific NTP. This regulation occurs at the active site. ATP or dATP can bind to activate or inhibit activity which allows for enzymatic activity to be controlled. Mutations can occur within the genome if there is an imbalance in the pools of dNTPs. These are the building blocks for DNA, and if the pool is altered, then it can lead to genomic instability. <ref name="disease">DOI:10.1038/onc.2014.155</ref> Having accurate DNA repair and replication allows for development, tumor-free cells, and growth. Having issues within the genome can cause several human diseases, mitochondrial disorders, and cause a person to be more susceptible to infection and cancer. High expressions of RNR is a main characteristic for cancers since it influences DNA replication so heavily. For this reason, RNRs play a major role in targeting anticancer and antibacterial drugs and therapies. RNR inhibitors are being studied to see if they can potentially serve as cancer treatment that is effective. More and more research is being done everyday in order to fully understand ribonucleotide reductase and all of its classes. For decades, dNTP machinery and RNR has been used and exploited for therapeutic benefits. They serve an important target for developing an efficient cancer drug. |
== Structure == | == Structure == | ||
| - | The structure of ribonucleotide reductase is composed of two components. One portion is the radical generator which produces and stores the radical. This portion is used to oxidize the substrate to its radical form which is the first step of the overall reaction. The second portion of the structure consists of a reductase. The reductase is the same for all three classes, but the radical generator differs. <ref name="structure"> | + | The structure of ribonucleotide reductase is composed of two components. One portion is the radical generator which produces and stores the radical. This portion is used to oxidize the substrate to its radical form which is the first step of the overall reaction. The second portion of the structure consists of a reductase. The reductase is the same for all three classes, but the radical generator differs. <ref name="structure">DOI:10.1016/S0079-6107(01)00014-1</ref> The three different classes of this enzyme have a cysteine residue that is located at the protein loop of the active site. The protein loop is in the center of the alpha, beta-barrel of the structural motif. The cysteine residue is conserved until it is converted to a thiyl radical. The conversion to the thiyl radical is needed to initiate substrate turnover. The different classes of RNR are different but do show some similarities which suggest that they all evolved from one common reductase. <ref name="pubmed">DOI:10.1016/j.bbapap.2004.02.007.</ref> |
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 18:30, 26 April 2022
Ribonucleotide Reductase
| |||||||||||
References
- ↑ 1.0 1.1 1.2 Torrents E. Ribonucleotide reductases: essential enzymes for bacterial life. Front Cell Infect Microbiol. 2014 Apr 28;4:52. doi: 10.3389/fcimb.2014.00052., eCollection 2014. PMID:24809024 doi:http://dx.doi.org/10.3389/fcimb.2014.00052
- ↑ Aye Y, Li M, Long MJ, Weiss RS. Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies. Oncogene. 2015 Apr 16;34(16):2011-21. doi: 10.1038/onc.2014.155. Epub 2014 Jun 9. PMID:24909171 doi:http://dx.doi.org/10.1038/onc.2014.155
- ↑ Eklund H, Uhlin U, Farnegardh M, Logan DT, Nordlund P. Structure and function of the radical enzyme ribonucleotide reductase. Prog Biophys Mol Biol. 2001 Nov;77(3):177-268. doi: , 10.1016/s0079-6107(01)00014-1. PMID:11796141 doi:http://dx.doi.org/10.1016/s0079-6107(01)00014-1
- ↑ doi: https://dx.doi.org/10.1016/j.bbapap.2004.02.007.
